Review



illumina mpseq kit  (Illumina Inc)


Bioz Verified Symbol Illumina Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Illumina Inc illumina mpseq kit
    ( A ) Blood is drawn before and after <t>surgery.</t> <t>DNA</t> from tumor is sequenced using the next-generation mate-pair sequencing <t>(MPseq)</t> protocol to identify chromosomal rearrangements. Several junctions are chosen to construct a personalized panel for each tumor. Percent of ctDNA out of total cfDNA is calculated at each time point of blood collection. ( B ) Number of junctions identified in cohort of 10 cases of serous stage 3 ovarian cancer. Count numbers are above the bars with the expected false negative count in parenthesis. cfDNA: cell-free DNA; ctDNA: circulating tumor DNA.
    Illumina Mpseq Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mpseq/pmc04951715-119-9-8?v=Illumina+Inc
    Average 90 stars, based on 1 article reviews
    illumina mpseq kit - by Bioz Stars, 2026-08
    90/100 stars

    Images

    1) Product Images from "Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers"

    Article Title: Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers

    Journal: Scientific Reports

    doi: 10.1038/srep29831

    ( A ) Blood is drawn before and after surgery. DNA from tumor is sequenced using the next-generation mate-pair sequencing (MPseq) protocol to identify chromosomal rearrangements. Several junctions are chosen to construct a personalized panel for each tumor. Percent of ctDNA out of total cfDNA is calculated at each time point of blood collection. ( B ) Number of junctions identified in cohort of 10 cases of serous stage 3 ovarian cancer. Count numbers are above the bars with the expected false negative count in parenthesis. cfDNA: cell-free DNA; ctDNA: circulating tumor DNA.
    Figure Legend Snippet: ( A ) Blood is drawn before and after surgery. DNA from tumor is sequenced using the next-generation mate-pair sequencing (MPseq) protocol to identify chromosomal rearrangements. Several junctions are chosen to construct a personalized panel for each tumor. Percent of ctDNA out of total cfDNA is calculated at each time point of blood collection. ( B ) Number of junctions identified in cohort of 10 cases of serous stage 3 ovarian cancer. Count numbers are above the bars with the expected false negative count in parenthesis. cfDNA: cell-free DNA; ctDNA: circulating tumor DNA.

    Techniques Used: Sequencing, Construct



    Similar Products

    mpseq  (Illumina Inc)
    96
    Illumina Inc mpseq
    Mpseq, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mpseq/bio_rxiv__64898__2026__02__01__701806-282-17-15?v=Illumina+Inc
    Average 96 stars, based on 1 article reviews
    mpseq - by Bioz Stars, 2026-08
    96/100 stars
    		  Buy from Supplier
    mpseq  (WholeGenome LLC)
    90
    WholeGenome LLC mpseq
    Mpseq, supplied by WholeGenome LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mpseq/pmc10119592-183-0-11?v=WholeGenome+LLC
    Average 90 stars, based on 1 article reviews
    mpseq - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    mpseq protocol  (Illumina Inc)
    90
    Illumina Inc mpseq protocol
    Mpseq Protocol, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mpseq/pmc06773761-51-0-5?v=Illumina+Inc
    Average 90 stars, based on 1 article reviews
    mpseq protocol - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    mate pair sequencing (mpseq)  (Illumina Inc)
    90
    Illumina Inc mate pair sequencing (mpseq)
    Mate Pair Sequencing (Mpseq), supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mpseq/pmc05091324-83-19-9?v=Illumina+Inc
    Average 90 stars, based on 1 article reviews
    mate pair sequencing (mpseq) - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    illumina mpseq kit  (Illumina Inc)
    90
    Illumina Inc illumina mpseq kit
    ( A ) Blood is drawn before and after <t>surgery.</t> <t>DNA</t> from tumor is sequenced using the next-generation mate-pair sequencing <t>(MPseq)</t> protocol to identify chromosomal rearrangements. Several junctions are chosen to construct a personalized panel for each tumor. Percent of ctDNA out of total cfDNA is calculated at each time point of blood collection. ( B ) Number of junctions identified in cohort of 10 cases of serous stage 3 ovarian cancer. Count numbers are above the bars with the expected false negative count in parenthesis. cfDNA: cell-free DNA; ctDNA: circulating tumor DNA.
    Illumina Mpseq Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mpseq/pmc04951715-119-9-8?v=Illumina+Inc
    Average 90 stars, based on 1 article reviews
    illumina mpseq kit - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A ) Blood is drawn before and after surgery. DNA from tumor is sequenced using the next-generation mate-pair sequencing (MPseq) protocol to identify chromosomal rearrangements. Several junctions are chosen to construct a personalized panel for each tumor. Percent of ctDNA out of total cfDNA is calculated at each time point of blood collection. ( B ) Number of junctions identified in cohort of 10 cases of serous stage 3 ovarian cancer. Count numbers are above the bars with the expected false negative count in parenthesis. cfDNA: cell-free DNA; ctDNA: circulating tumor DNA.

    Journal: Scientific Reports

    Article Title: Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers

    doi: 10.1038/srep29831

    Figure Lengend Snippet: ( A ) Blood is drawn before and after surgery. DNA from tumor is sequenced using the next-generation mate-pair sequencing (MPseq) protocol to identify chromosomal rearrangements. Several junctions are chosen to construct a personalized panel for each tumor. Percent of ctDNA out of total cfDNA is calculated at each time point of blood collection. ( B ) Number of junctions identified in cohort of 10 cases of serous stage 3 ovarian cancer. Count numbers are above the bars with the expected false negative count in parenthesis. cfDNA: cell-free DNA; ctDNA: circulating tumor DNA.

    Article Snippet: DNA from primary tumor was prepared using the Illumina MPseq Kit following the manufacturer’s instructions and sequenced as two libraries per lane on the Illumina HiSeq2000 platform .

    Techniques: Sequencing, Construct